Yup, along with the fact that Pfizer have the biggest contract with the EU so should also comprise the highest proportion of the vaccine supply, not to mention their head start in production and approval.
With a supposed extra dose possible from each vile, you can increase that by 20% as well.
By the sounds of things they are working their holes off to get more production capacity by February but it isn’t set in stone so some caution.
If he is right about about AZ I don’t see any reason why we couldn’t have 800k of Pfizer by the end of March which would allow for an additional 220k to be vaccinated. Along with some doses of J&J coming through you’d hope we’d in reality be close enough to have the over 60s group finished, which really would be the back broken on this thing.
But the EU’s contract on the vaccine supply is 3:2 Pfizer-OxAZ so I’m wondering how your man’s data has the AZ supply being close to 3x that of Pfizer up until March?
Is there any reason why Ox/AZ hadn’t applied to the EU and why the EU were not chasing them? It’s seems to be the best hope we have of getting things rolled out quickly.
The Oxtrazeneca trial was a bit of a farce. It shouldn’t have been approved by the UK on the basis of the info they had at the time. They were happy enough then once the UK approved as they’ve only a limited supply anyway. The trial is more complete since and it looks like the EUrocrats are going to get steam rolled by Merkel and co into approving